Recent Studies Revealed that Marijuana May Help A Patient With Parkinson's Disease

By abbie uychiat

SAN FRANCISCO - APRIL 24: A worker at the Alternative Herbal Health Services cannabis dispensary rolls a marijuana cigarette April 24, 2006 in San Francisco, California. The Food and Drug Administration issued a statement last week rejecting the use of medical marijuana declaring that there is no scientific evidence supporting use of the drug for medical treatment. (Photo : Justin Sullivan / Staff) 

 

Marijuana is known to have numerous medical benefits, and as of the most recent news, FDA admitted that marijuana can in fact cure cancer. Cancer and chronic pain may be the most common ailments that marijuana can cure, but recent studies revealed that Cannabidol, a compound found in pot, can help manage Parkinson's disease.






As per Leaf Science, "New research suggests a compound in marijuana can help manage symptoms of Parkinson's disease." It is a chronic, degenerative disorder that usually targets elderly people. One of which is Alzheimer's, which is known to be a disease where in an elderly would have a progressive loss of neurons in the brain.

a recent studies emerged that cannabidiol, which is a non-psychoactive compound that is naturally produced by the marijuana plant. It has an anti-inflammatory and anti-oxidant property that has the potential to treat Alzheimer's.

As per Green Med info website Parkinson's disease have  no effective treatment at present. The primary treatment however involves the usage of doapamine increasing drugs that can possibly increase a 6-hydroxy-doapamine, which can however accelerate the progression of the disease. 

This being said, rec]searchers have been looking for ways that would have less harmful effects, which is why they opted to try incorporating the marijuana compound cannabidiol.

"In the first one, Lastres-Becker et al. (2005) showed that the administration of CBD counteracted neurodegeneration caused by the injection of 6-hydroxy-dopamine in the medial prosencephalic bundle, an effect that could be related to the modulation of glial cells and to antioxidant effects (Lastres- Becker et al., 2005).

In the next year, Garcia-Arencibia et al. (2007) tested many cannabinoid compounds following the lesion of dopaminergic neurons in the substantia nigra with 6-hydroxy-dopamine and found that the acute administration of CBD seemed to have a neuroprotective action; nonetheless, the administration of CBD one week after the lesion had no significant effects (Garcia-Arencibia et al., 2007).

This study also pointed to a possible antioxidant effect with the upregulation of  mRNA of the enzyme Cu-Zn-superoxide dismutase following the administration of CBD." 

As of the study's conclusion, the website reported that it did have positive effects on three of the human clinical trials that was conducted using cannabidiol's neuroprotective effects.